Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 241,963 | 205,831 | 231,041 | 211,699 | 165,235 |
| Cost of Goods | 18,230 | 22,951 | 17,890 | 14,622 | 7,459 |
| Gross Profit | 223,733 | 182,880 | 213,151 | 197,077 | 157,776 |
| Operating Expenses | 193,526 | 168,621 | 179,097 | 255,475 | 155,198 |
| Operating Income | 30,437 | 15,210 | 34,944 | -57,776 | 3,037 |
| Other Income | 6,745 | 5,792 | 4,759 | 5,633 | 3,306 |
| Pre-tax Income | 37,182 | 21,002 | 39,703 | -52,143 | 6,343 |
| Income Tax | 3,793 | 4,447 | -6,094 | 13,033 | 5,229 |
| Net Income Continuous | 33,389 | 16,555 | 45,797 | -65,176 | 1,114 |
| Net Income | $33,389 | $16,555 | $45,797 | $-65,176 | $1,114 |
| EPS Basic Total Ops | 0.20 | 0.10 | 0.29 | -0.40 | 0.01 |
| EPS Basic Continuous Ops | 0.20 | 0.10 | 0.28 | -0.40 | 0.01 |
| EPS Diluted Total Ops | 0.20 | 0.10 | 0.29 | -0.40 | 0.01 |
| EPS Diluted Continuous Ops | 0.20 | 0.10 | 0.28 | -0.40 | 0.01 |
| EPS Diluted Before Non-Recurring Items | 0.20 | 0.10 | 0.28 | -0.40 | 0.01 |
| EBITDA(a) | $31,054 | $18,952 | $34,802 | $-58,049 | $3,312 |